News | EnvisionRxOptions

Albertsons Companies and Rite Aid Merge to Create Food, Health and Wellness Leader

Combination Will Create Strong Local Networks in Attractive Geographies

Integrated Platform Will Provide Customers Greater Choice, Convenience, and Access, and Accelerate Omni-Channel Strategy to Reach More Customers and Drive Profitable Growth

John Standley to Serve as Chief Executive Officer and Bob Miller to Serve as Chairman of Combined Company

Transaction Expected to Generate Run Rate Cost Synergies of $375 Million and Create Incremental Revenue Opportunities of Over $3.6 Billion

Combined Company Expected to Generate Pro Forma 20181 Revenues of $83 Billion and Adjusted Pro Forma EBITDA of $3.7 Billion (Including Run Rate Cost Synergies)

shutterstock_133606469-man-select-pill-bottles-duo_275x160.jpg

PRESS RELEASE: EnvisionRx, a pharmacy benefit manager (PBM) and division of EnvisionRxOptions, a wholly owned subsidiary of Rite Aid Corporation, today announced it has achieved renewal of the Drug Therapy Management (DTM) accreditation by URAC. This accreditation recognizes healthcare organizations that provide innovative ways to manage and incorporate DTM into their clinical care management programs. EnvisionRx is one of only four organizations to accomplish this accreditation, which Envision has held since 2007.

Depositphotos_4719382_original_Woman_Mutliple_Pill_Bottles Duo_1000x664.jpg

PRESS RELEASE: EnvisionRx , a pharmacy benefit manager (PBM) and division of EnvisionRxOptions, a wholly owned subsidiary of Rite Aid Corporation , today announced that it has achieved renewal of the Pharmacy Benefit Management accreditation by URAC. EnvisionRx is one of only 27 PBMs to receive this accreditation, which Envision has held since 2006. This demonstrates a continuous, comprehensive commitment to quality care, improved processes, transparency and better patient outcomes.

Learn More About EnvisionRxOptions

Latest News